Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.59 -0.03 (-4.22%)
As of: Oct 22, 2026 · 9:43 AM EDT

Scinai Immunotherapeutics (SCNI) EV to FCF (2023)

Updated

Analysis

Scinai Immunotherapeutics (SCNI) EV to FCF (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn
10 Scinai Immunotherapeutics 136,612.96 -8.13 Mn -1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.00
API Access

Scinai Immunotherapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=SCNI&period=max&api_key=YOUR_API_KEY